Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma

Clinical trial NCT07303283 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07303283
Sponsor: Kai Hu
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma (NPC)Locoregionally Advanced Nasopharyngeal Carcinoma Adjuvant Therapy

Start date: 2026-09-01
Primary completion: 2030-08-31
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.